PTU - Polskie Towarzystwo Urologiczne
list of articles:

The attempt to estimation renal insufficiency risk factors after nephron-sparing surgery (NSS) in patients with neoplasmatic tumor of solitary kidney
Article published in Urologia Polska 2007/60/1.


Mieczysław Fryczkowski, Andrzej Kupilas, Andrzej Paradysz, Maciej Szczębara
Katedra i Klinika Urologii w Zabrzu Śląskiej Akademii Medycznej w Katowicach


ren solitaris, neoplasmatic tumor, NSS, kidney insufficiency


Introduction. Renal insufficiency as well as oncologic radicality plays an important role in surgical nephron-sparing surgery (NSS) in patients with solitary kidney tumor.
Material and method. Retrospective analysis was performed in 27 patients who undergone NSS in period 5-103 months before. Patients were analysed in 2 groups: I group consisted of 14 patients suffered from renal insufficiency, II group consisted of 13 patients without renal insufficiency. In both groups morphological and clinical factors of renal insufficiency were considered. In 8 patients parenchymal resection was applied, 19 patients undergone tumor excavation (enucleoresectio). Follow-up was performed accoording to EORTC guidelines.
Results. In I group in comparison to II analysis revealed higher percentage of tumor grade G2-4, multifocality, and tumors of upper pole of the kidney. There was no statistically significant difference in death percentage and disease progression during significant shorter period of observations in I group. Excavation did not reveal in comparison to resection, statistically significance in oncologic results however percentage of patients with renal insufficiency was decreased. In above 40 percent of patients with medium and mild degree of renal insufficiency we observed it withdrawal after compensation period assisted with protective diet and /or pharmacotherapy.
Conclusion. 1. Tumor excavation in patients with solitary kidney is procedure which increases nephrologic safety and gives similar oncologic radicality in comparison to parenchymal resection. 2. Poor prognosis factors are preoperative renal insufficiency, tumor over 4 cm diameter, multifocality, over 10 years period of living with solitary kidney, low differentiation of tumor cell, and tumor location in upper pole. 3. In above 40% of patients with medium and mild grade of renal insufficiency after NSS assisted compensative function increase of remnant renal parenchyma in solitary kidney. This leads to its normalization, decreasing the need of dializotherapy and improves patients quality of life.


  1. Brenner BM: Hemodynamically mediated glomerular injury and the progressive nature of kidney disease. Kidney Int 1983, 23, 647-650.
  2. Holtl G, Todoroff K, Ubelhor R, Zinnbauer B: Renales minimum; in Ubelhor R, Figdor PP; Urologische Nephrologie. Munchen Urban und Schwaizenberg 1976, pp. 109-112.
  3. McKiernan J, Simmons R, Katz J, Russo P: Natural history of chronic renal insufficiency after partial and radical nephrectomy. Urology 2002, 59, 816-820.
  4. Fotino S: The solitary kidney: a model of chronic hyperfitration in humans. Am J Kidney Dis 1989, 13, 88-98.
  5. Novick AC, Schreiber MJ: Effect of angiotensin-converting enzyme inhibition on nephropathy in patients with a remnant kidney. Urology 1995, 46, 785-789.
  6. Adkins KL; Chang SS, Cookson MS, Smith JA: Partial nephrectomy safely preserves renal function in patients with a solitary kidney. J Urol 2003, 169, 79-81.
  7. Novick AC, Gephardt G, Guz B, Steinmuller B, Tubbs RR: Long-term follow-up after partial removal of a solitary kidney. N Engl J Med 1991, 325, 1058-1062.
  8. Pozi MK, Pal WF, Hendrey SL: The outcome of partial nephrectomy for renal cell carcinoma in patients with a solitary kidney. Br J Urol1998, 81, supl. 4, abstr. F-69.
  9. Peterson B, Ghavamian RC, Wallan C et al: Extended autcome of renal preserving surgery in solitary kidney. J Urol 1998, 159, supl. 3, abstr. 764.
  10. Forster MN, Sant GH, Donohe F, Harrington JF: Prolonged survival with a remnant kidney. Am J Kidney Dis 1991, 17, 261-264
  11. Morgan WR, Zincke MH: Progression and survival after renal-conserving surgery for renal cell carcinoma: experience in 104 patients and extended followup. J Urol 1990, 144, 852-857.
  12. Ghavamian R Ghavanian R, Cheville JC, Lohse CM et al: Renal cell carcinoma in the solitary kidney: an analysis of complications and outcome after nephron sparing surgery. J Urol 2002, 168, 454-459.
  13. Smith RB, de Kernion JB, Ehrlich RM, et al: Bilateral renal cell carcinoma and renal cell carcinoma in the solitary kidney. J Urol 1994, 152, 450-454
  14. Lau WK, Blute ML, Zincke H: Matched comparison of radical nephrectomy versus elective nephron-sparing surgery for renal cell carcinoma (RCC). Evidence for increased renal failure rate on long-term follow-up (>10 years). J Urol 2000, 163, supl. 4, abstr. 681.
  15. Fryczkowski M, Kupilas A, Paradysz A i in: Porównanie wyników operacji organooszczędzających nerki (NSS) z marginesem chirurgicznym szerokości do 3 mm i powyżej 5 mm u chorych na raka nerki. Urol Pol 2005, 2, 103-107.
  16. Puppo P, Intraini C, Majetta L et al: Nephron-sparing surgery leaving 2-3 mm margin. Review of 94 cases. Eur Urol 2003, supl. 1, abstr. 214.
  17. Wunderlich H, Reichelt D, Schumann Schuman S et al: Nephron-sparing surgery for renal cell carcinoma 4 cm or less in diameter: indicated or under treated? J Urol. 1998, 159, 1465-1469.
  18. Jeromin L, Wrona M, Lipiński M, Marks F Marks P: Własne doświadczenia w leczeniu operacyjnym guza jedynej nerki sprawnej. Urol Pol 1996, supl. 3a, abstr. 120.
  19. Krishnamurthi V, Novick AV, El Fettouh BA, Charutto EE: The management of multifocal sporadic localized renal cell carcinoma by nephron nephrom-sparing surgery. Long-term outcomes. J Urol 2001, 165, supl. 5, abstr. 653.
  20. Lesvee PM., Denher AJ: Renal reserve filtration capacity can it prediet progression of chronic renal failare. Am J Kidney Dir 1991, 17, syg. 1. A6 71
  21. Brenner BM, Lawler, Moc Fenzie KS: The hyperfiltration theory: a paradigm shift in nephrology. Kidney Int. 1996, 49, 1774-1777.


Mieczysław Fryczkowski
Klinika Urologii ŚAM
ul. 3 Maja 13/15
41-800 Zabrze
tel./fax (032) 271 65 11